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Background:  Given the widespread overuse of antipsychotic medications among US nursing home (NH) 
residents, we sought to identify knowledge of and perceived need for the AHRQ Comparative 
Effectiveness Research Summary Guide (CERSG) “Off-Label Use of Atypical Antipsychotic Drugs”.  
 
Methods:  We conducted a baseline needs assessment with 12 NHs participating in a randomized 
controlled trail evaluating evidence dissemination strategies. Using a mixed method approach, we 
conducted in-depth assessments of knowledge, attitudes, and practice behavior using telephone 
interviews with NH leadership (administrators, directors of nursing [DON], and medical directors), and 
questionnaires with NH leadership, consultant pharmacists and direct care staff. Interviews were 
transcribed, verbatim responses were coded independently by 2 project staff. The coding scheme was 
revised after each round until substantial agreement (85%) was reached.  
 
Results:  Interviews revealed that 70% of medical directors and 46% of DON and administrators believed 
that antipsychotics decreased agitation and controlled harmful behavior; 50% of medical directors and 
7% of DONs & administrators reported knowledge of the increased risk of morbidity and mortality due 
to atypical antipsychotics. Half of administrators and DONs expressed interest in receiving information 
for NH staff pertaining to understanding dementia and dementia-related behaviors, 42% believed 
families would benefit from information about antipsychotic use for dementia-related behaviors. 
Questionnaire results were similar. When leaders were asked to list any risks associated with 
antipsychotic use for residents with dementia, only 17% reported death as a possible adverse event; 
licensed nursing staff (RN and LPNs) reported death 5% of the time.  Over half of consultant pharmacists 
identified that their biggest barrier to improving medication use in challenging NHs was physician 
resistance to accepting recommendations. 
 
Conclusions:  The responses of the NH leaders, staff and consultant pharmacists suggest widespread 
knowledge gaps regarding antipsychotic benefits and risks, and suggest a need for increase evidence 
dissemination and broad organizational change. 
